[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.Read more
CTA approval by the ANSM and the EC of the phase 1 program resulting from the collaboration between Servier and OPM for the development of an innovative treatment in Parkinson's disease...
28% growth in Service turnover
Check out where to meet Oncodesign this spring... surely we can arrange a meeting somewhere.
Read the full press release about our very good results in 2021 & an attractive outlook for 2022 for the group & our BUs Service, Biotech & AI.
Find all the 2021 financial information: 2021 turnover of €31.3M, up by 22%, and expects to break even and dive into the BU financial results
Oncodesign announces all the regulatory dates as far as financial information is concerned. Let's have a look :)
EHDEN network will enable transparent & fully reproducible research by standardizing both the health data & the analytical pipeline.
Oncodesign adds a new high-level competence to its COMEX to achieve its external growth objectives with Karine Lignel.
Oncodesign strenghens its Board by appointing Aline Aubertin as new independent director.
Oncodesign Find out how we built our logo! trajectory DNA innovation...green and bleue pharma colors Find out how we built our logo!